ACE-083

· Acceleron Pharma, Inc. (a Merck & Co. subsidiary)

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ACE-083, covering 2019-07-08 to 2021-07-28. Get the full timeline:

Most recent: Clinical Trial Update: Study of ACE-083 in Patients With Charcot-Marie-Tooth Disease [Phase 2]